Comparative proteomic analysis of human pancreatic juice: methodological study

Area of Science:

• Proteomics
• Biomarker Discovery
• Gastroenterology

Background:

• Pancreatic cancer is a highly lethal malignancy with a critical need for early detection markers.
• Current diagnostic methods have limitations, necessitating novel approaches for timely identification.

Purpose of the Study:

• To optimize and apply proteome analysis of human pancreatic juice for identifying pancreatic cancer biomarkers.
• To compare protein profiles in pancreatic juice from cancer patients versus benign disease controls.

Main Methods:

• Collected uncontaminated pancreatic juice samples during endoscopic retrograde cholangiopancreatography (ERCP).
• Utilized ultramembrane centrifugation, 2-DE (two-dimensional gel electrophoresis), and MALDI-TOF-MS (matrix-assisted laser desorption/ionization-time of flight mass spectrometry) for proteomic analysis.
• Compared protein expression in pancreatic juice from pancreatic cancer patients and non-malignant controls with similar pancreatic duct obstruction.

Main Results:

• Established a 2-DE dataset of pancreatic juice from patients with cholelithiasis, identifying 22 distinct proteins.
• Found that pancreatic duct obstruction significantly alters pancreatic juice protein composition.
• Identified seven protein spots with consistently altered levels in pancreatic juice from pancreatic cancer patients compared to controls.

Conclusions:

• Comparative proteomic analysis of human pancreatic juice is a viable strategy for discovering pancreatic cancer biomarkers.
• The identified protein changes may serve as indicators for early pancreatic cancer detection.